TG Therapeutics Inc (TGTX) USD0.001

Sell:$38.20Buy:$38.32Price increased$2.03 (5.60%)

Prices delayed by at least 15 minutes
Sell:$38.20
Buy:$38.32
Change:Price increased$2.03 (5.60%)
Deal now
Prices delayed by at least 15 minutes
Sell:$38.20
Buy:$38.32
Change:Price increased$2.03 (5.60%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$36.48
Previous close$36.28
Market cap$5.79bn
P/E ratio13.83
Volume2,297,723
Dividend yield0.00%
EMS-

Company information

TG Therapeutics, Inc. is a fully integrated, commercial stage biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its products include Ublituximab ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue163.23m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.